Actively Recruiting
xPedite: A Study to Expedite DIPG and DMG Research
Led by xCures · Updated on 2024-04-30
400
Participants Needed
1
Research Sites
165 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will gather data from new and existing patients with patient medical records, and patient/family/caregiver reported information to establish a clear natural history of disease suitable to serve as an external, contemporary or historical control arm for future therapeutic development programs of drugs, devices, or biologic interventions in DMG or DIPG.
CONDITIONS
Official Title
xPedite: A Study to Expedite DIPG and DMG Research
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of diffuse midline glioma or diffuse intrinsic pontine glioma (DIPG) as defined by WHO 2021 criteria, or grade IV glioma involving specified brain regions without pathological confirmation
- Patients of any performance status, comorbidity, or disease severity
- Willingness and ability to provide electronic informed consent or have a legally authorized representative to do so
- Informed consent obtained for the XCELSIOR longitudinal outcomes registry (NCT03793088)
- Residency or receipt of care within the United States or US territories
You will not qualify if you...
- Unable to provide informed consent personally or via legally authorized representative
- Unable to complete patient-reported and clinician-reported outcome assessments electronically
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
xCures, Inc.
Los Altos, California, United States, 94022
Actively Recruiting
Research Team
X
xCures Study Team
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here